Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLNX
3701
CALL
DELISTED
Xilinx Inc
XLNX
| $2.31M | ﹤0.01% |
+15,300
| New | +$2.24M |
|
3702
IES Holdings
IESC
$14.4B
| $2.31M | ﹤0.01% |
+50,491
| New | +$2.45M |
|
3703
CarParts.com
PRTS
$44.2M
| $2.31M | ﹤0.01% |
14,779
+1,423
| +11% | +$247K |
|
3704
Lincoln Electric
LECO
$14.6B
| $2.3M | ﹤0.01% |
17,864
+8,110
| +83% | +$1.1M |
|
|
TWOU
3705
CALL
DELISTED
2U Inc
TWOU
| $2.3M | ﹤0.01% |
2,283
-1,520
| -40% | -$1.78M |
|
|
ACB
3706
Aurora Cannabis
ACB
$175M
| $2.3M | ﹤0.01% |
+33,218
| New | +$2.36M |
|
|
FOREU
3707
DELISTED
Foresight Acquisition Corp. Units
FOREU
| $2.3M | ﹤0.01% |
226,306
-37,570
| -14% | -$384K |
|
3708
PUT
Quince Therapeutics
QNCX
$24.4M
| $2.29M | ﹤0.01% |
+125
| New | +$1.99M |
|
|
LFC
3709
DELISTED
China Life Insurance Company Ltd.
LFC
| $2.29M | ﹤0.01% |
280,777
-323,626
| -54% | -$2.77M |
|
|
CYBE
3710
DELISTED
Cyberoptics Corp
CYBE
| $2.29M | ﹤0.01% |
64,336
+8,334
| +15% | +$340K |
|
|
VCRA
3711
CALL
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.29M | ﹤0.01% |
+50,000
| New | +$2.23M |
|
|
HBMD
3712
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $2.29M | ﹤0.01% |
+112,824
| New | +$2.16M |
|
3713
Evertec
EVTC
$1.92B
| $2.29M | ﹤0.01% |
50,025
+1,940
| +4% | +$87.5K |
|
3714
Anavex Life Sciences
AVXL
$273M
| $2.29M | ﹤0.01% |
127,359
+28,391
| +29% | +$565K |
|
3715
Buckle
BKE
$2.37B
| $2.29M | ﹤0.01% |
57,746
-585,463
| -91% | -$25M |
|
3716
Primerica
PRI
$9.89B
| $2.29M | ﹤0.01% |
14,878
-5,226
| -26% | -$778K |
|
|
SLI
3717
Standard Lithium
SLI
$510M
| $2.28M | ﹤0.01% |
+279,674
| New | +$1.85M |
|
3718
Organon & Co
OGN
$3.56B
| $2.27M | ﹤0.01% |
69,328
-349,487
| -83% | -$11.2M |
|
3719
PUT
Darden Restaurants
DRI
$23.6B
| $2.27M | ﹤0.01% |
+15,000
| New | +$2.2M |
|
|
NREF
3720
NexPoint Real Estate Finance
NREF
$327M
| $2.27M | ﹤0.01% |
+116,539
| New | +$2.41M |
|
3721
iShares MSCI China ETF
MCHI
$6.31B
| $2.27M | ﹤0.01% |
+33,600
| New | +$2.42M |
|
3722
Pebblebrook Hotel Trust
PEB
$2.18B
| $2.27M | ﹤0.01% |
101,061
+36,106
| +56% | +$799K |
|
|
FOLD
3723
DELISTED
Amicus Therapeutics
FOLD
| $2.26M | ﹤0.01% |
236,959
+190,124
| +406% | +$1.94M |
|
3724
PUT
Peloton Interactive
PTON
$2.79B
| $2.26M | ﹤0.01% |
26,000
-18,700
| -42% | -$2.07M |
|
|
WW
3725
PUT
DELISTED
WW International
WW
| $2.26M | ﹤0.01% |
124,000
| – | – |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.